This study was aimed at investigating whether the blockade of a,-adrenergic receptors could reduce portal pressure in cirrhosis. Splanchnic and systemic hemodynamics were measured in 12 cirrhotic patients with esophageal varices at baseline and 1 hr after oral administration of 2 mg of prazosin (acu
The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension
โ Scribed by Siddarth Ganguly; Shiv K. Sarin; Vivek Bhatia; Deepak Lahoti
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 673 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
Portal hypertension diffusely affects the gastrointestinal tract. The frequency and profile of distinct colonic mucosal lesions (portal colopathy) and rectal varices (RV; veins >4 cm above the anal verge) is not well studied. Fifty consecutive patients with portal hypertension (25 with cirrhosis, 10 with noncirrhotic portal fibrosis [NCPF], and 15 with extrahepatic portal vein obstruction [EHPVO]) were assessed clinically and by upper and lower gastrointestinal (GI) endoscopy. Colorectal lesions were seen in 35 (70%) patients, significantly more often in bleeders than in nonbleeders. Rectal varices were detected in 22 (44%) patients; larger and more often seen in EHPVO (80%) than in cirrhosis (28%) and NCPF (30%) (P < .01) patients. Portal colopathy was seen in 26 (52%) patients, with nearly similar frequency in cirrhotics, NCPF, and EHPVO patients. Previous sclerotherapy or presence of gastric varices had little influence on the development of these lesions. An association (P < .01) was, however, seen between the presence of colopathy and portal gastropathy. Overt bleeding was seen in 8% and 4% of patients with RV and colopathy, respectively. In conclusion, our results demonstrate that colorectal lesions are present in about two thirds of patients with portal hypertension. Patients with portal hypertension and lower GI bleeding should be colonoscoped. Patients with extrahepatic portal vein obstruction may in turn benefit from baseline sigmoidoscopic examination to define the presence and size of rectal varices. (HEPATOLOGY 1995;21:1226-1231.) Portal hypertensive gastropathy (PGP) due to portal hypertension is now a well-recognized distinct entity.'.' Because the effect of raised portal pressure could be generalized, the mucosa in other parts of the gut could also be involved. Colonic mucosal lesions akm to mucosal changes in PGP have been described in selected groups of portal hypertension patient^.^,^ The exact prevalence Abbreviations: PGP, portal hypertensive gastropathy; NCPF, noncirrhotic portal fibrosis; EHPVO, extrahepatic portal vein obstruction; GI, gastrointestinal: KV, rectal varices.
๐ SIMILAR VOLUMES
## AND JCAN RODES~ Gastric mucosal perfusion is increased in portalhypertensive gastropathy, and this may contribute to gastric bleeding from these lesions. Therefore drugs reducing gastric mucosal perfusion may be beneficial in the treatment of overt bleeding from portal-hypertensive gastropathy.
Nodular regenerative hyperplasia (NRH) is an uncommon hepatic lesion often associated with noncirrhotic portal hypertension (PHT). We have noted that NRH and PHT are frequent occurrences in a colony of dogs with the genetic storage disease, mucopolysaccharidosis I (MPS-I). This observation provides
## Purpose: Using the color doppler velocity profile (cdvp), we investigated portal hemodynamics and their relationship with esophageal variceal bleeding (evb) in patients with cirrhosis and portal hypertension. ## Methods: The hemodynamics of the portal trunk, right anterior portal branch, and s
In recent years many studies have suggested that somatostatin may be useful in the treatment of patients with bleeding esophageal varices, although there is still some controversy on this point (1-5). The mechanisms through which somatostatin exerts its beneficial therapeutic effects in patients wit